- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05350735
Phone Text Message Reminders on Compliance With Human Rabies Post Exposure Prophylaxis Project
Effect of Phone Text Message Reminders on Compliance With Rabies Post-Exposure Prophylaxis Following Dog-Bites in Rural Kenya
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Rabies is a fatal viral disease transmitted to humans mainly by domestic dogs. It is a neglected zoonosis that primarily affects underserved populations that have limited access to health care. Every year, rabies is estimated to kill 59,000 people globally, mostly children 15 years and below in Africa and Asia. This is despite the development of effective vaccines against rabies in humans, and in dogs. Although rabies is always fatal once clinical signs manifest, the disease is preventable with timely treatment after exposure to the rabies virus. The World Health Organization (WHO) recommend that bite patients should receive thorough wound cleaning with soap and water for approximately 15 minutes, followed by administration of anti-rabies vaccine on the day of the bite, as well as additional injections over the course of one month. Bite patients with multiple severe bites particularly to the head and upper trunk, infiltration of rabies immunoglobulin into and around the wound is added. Poor availability of rabies vaccines, lack of access to anti-rabies vaccine or deviations from WHO recommendations such as delays in seeking anti-rabies vaccine and incomplete courses of the vaccine increases the risk of clinical rabies and death. Access to mobile phones has increased globally including in rural settings presenting an opportunity to use them to enhance access to health interventions. Text message reminders has been shown to improve patient compliance including for childhood immunization attendance and appointment reminders across different geographical settings and health care services.
Objective: To assess the effect of SMS reminders on compliance with the five-dose Essen rabies vaccine regimen and determine the factors associated with compliance among dog-bite patients.
Methods: The investigators employed a single arm before-after field trial among patients presenting with dog bites in Makueni County Referral Hospital between October 2018 to March 2019. The study participants were allocated to one of two groups: group 1: bite patients enrolled between January - March 2019 who received a medical card at the first day of visiting the health facility indicating return date for the subsequent dose, and SMS reminders a day before the next dose of anti-rabies vaccine. The SMS messages were written in both English and the local dialect, Kamba; group 2: bite patients recruited into the study between October and December 2018 before the SMS reminder was introduced, this group was designated as the control group. Every bite patient routinely receives a medical card indicating return date for the subsequent dose. To collect data on other factors affecting completion and adherence to the five doses of anti-rabies vaccine, a phone interview was completed to all study participants after at least a month from the bite time.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Makueni, Kenya
- Makueni County Referral Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants will be patients of any age reporting to the health facility with dog bites.
- Participants (dog-bite patients or next of kin) in possession of mobile phones.
- Participants (dog-bite patients) consenting to and participating in a phone interview after the last date of the scheduled anti-rabies vaccine dose.
- In the intervention arm - participants acknowledging receipt of SMS text reminders.
Exclusion Criteria:
- Participants (dog-bite patient) that do not consent to participate in the study.
- Participants that do not own mobile phones.
- Participants in the intervention arm that did not receive SMS reminders despite owning mobile phones.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm: SMS text reminders and medical card
Participants in this intervention arm will receive the routine medical card indicating return date for the subsequent doses of anti-rabies vaccine and SMS reminders sent a day before each dose until the scheduled date of the last dose of anti-rabies vaccine.
|
This study arm will assess compliance with anti-rabies vaccine regimen by participants in the presence of SMS text reminders as compared to without the SMS reminder.
|
|
No Intervention: Control arm: Medical card
Participants in the control arm will receive the routine medical card indicating return date for the subsequent doses of anti-rabies vaccine.
No SMS text reminders will be sent to this group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants that complete the five-dose Essen rabies vaccine regimen in the control versus intervention group
Time Frame: 7 months
|
The number anti-rabies vaccine doses received by each participant will be reviewed from ant-rabies vaccine register placed at the health facility where participants are recorded after receiving an injection.
The investigators will also conduct a phone interview with the participants to determine the number of doses received (using a questionnaire).
The investigators will then determine if SMS reminders are associated with completion of the five doses of anti-rabies vaccine.
|
7 months
|
|
Number of participants adhering to the scheduled date of the five-dose Essen rabies vaccine regimen.
Time Frame: 7 months
|
The number of participants adhering to the scheduled date of anti-rabies vaccine doses will be reviewed from ant-rabies vaccine register placed at the health facility where participants are recorded after receiving an injection.
The investigators will also conduct a phone interview with the participants to investigate the exact dates participants received the anti-rabies vaccine injections.
The investigators will then determine if SMS reminders are associated with adherence to the five doses of anti-rabies vaccine.
|
7 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thumbi Mwangi, PhD, Washington State University, Paul G Allen School for Global Animal Health
- Study Director: Veronicah M Chuchu, PhD(c), Washington State University - Global Health Kenya
- Study Director: Mutono Nyamai, PhD(c), Washington State University - Global Health Kenya
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KEMRI/SERU/CGHR/046/3268
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rabies
-
The Methodist Hospital Research InstituteGrifols Biologicals, LLCCompletedRabies | Rabies Human | Rabies Virus InfectionUnited States
-
Centers for Disease Control and PreventionCompletedRabies Prevention | Rabies ExposureUnited States
-
The Methodist Hospital Research InstituteGrifols Biologicals, LLCTerminatedRabies | Rabies Human | Pediatrics | Rabies Virus InfectionUnited States
-
Changchun BCHT Biotechnology Co.Enrolling by invitation
-
Lanzhou Institute of Biological Products Co., LtdNot yet recruitingRabies (Healthy Volunteers)China
-
Institute of Tropical Medicine, BelgiumNot yet recruitingRabies (Healthy Volunteers)Belgium
-
Sinovac Biotech Co., LtdNot yet recruitingRabies (Healthy Volunteers)China
-
Sinovac Biotech Co., LtdCompletedRabies (Healthy Volunteers)China
-
Synermore Biologics (Suzhou) Co., Ltd.Peking University First Hospital; Hunan Provincial People's Hospital; Shenzhen... and other collaboratorsRecruitingRabies Post-exposure ProphylaxisChina
-
Synermore Biologics (Suzhou) Co., Ltd.Active, not recruitingRabies | Rabies Post-exposure ProphylaxisChina
Clinical Trials on Intervention arm: SMS text reminders and medical card
-
Harvard Medical School (HMS and HSDM)Partners in HealthActive, not recruitingCOVID-19 | Mental Health | MisinformationHaiti, Malawi, Rwanda
-
University of the PhilippinesDepartment of Health, PhilippinesCompletedHypertensionPhilippines
-
Addis Ababa UniversityRecruitingSuspicious Cervical Cancer Lesions Follow up AdherenceEthiopia
-
Centers for Disease Control and PreventionBill and Melinda Gates Foundation; Ministry of Health, Uganda; African Field... and other collaboratorsCompletedHepatitis B | Measles | Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Influenzae Type b Infection
-
Columbia UniversityPfizerCompletedVaccinationUnited States
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)CompletedHIV InfectionUnited States
-
Boston UniversityNational Institute of Mental Health (NIMH)CompletedHIV/AIDS | ViolenceSouth Africa
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnLung Non-Small Cell Carcinoma | Lung Carcinoid Tumor | Caregiver | Lobectomy Patient
-
University of Texas, El PasoNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingPhysical Activity | Activity TrackersUnited States
-
Joslin Diabetes CenterBaylor College of Medicine; National Institute of Diabetes and Digestive and...CompletedType 1 DiabetesUnited States